| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.05 |